Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.

By J. Koreth, R. Schlenk, K. Kopecky, S. Honda, J. Sierra, B. Djulbegovic, M. Wadleigh, D. DeAngelo, R. Stone, H. Sakamaki and 5 more. Journal of the American Medical Association (JAMA), 2009

853 citations recorded by the source corpus.

Subfields: Hematology

View Paper: https://www.semanticscholar.org/paper/11f2e43bea3e280c92b3a6ed2c4d351a75fad42d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. S. Cooley
2. D. Weisdorf
3. L. Guethlein
4. Tao Wang
5. Peter Parham
6. John P. Klein
7. C. Le
8. S. Marsh

Citations in the corpus

• Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. (2010, methodology): “On the basis of this analysis, donor KIR B–content groups are divided as: (1) “best” with a KIR B–content score of more than 2 where the KIR haplotype is Cen-B/B, Tel-x/x (defined as 2DL3 absent, 2DS2 and/or 2DL2 present); (2) “better” with a KIR B–content score of more than 2 and the KIR haplotype ”